{"mainPropery":{"diseaseId":3319,"diseaseName":"Lymphangioleiomyomatosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/3319/lymphangioleiomyomatosis","synonyms":["LAM","Lymphangio-myomatosis"],"synonyms-with-source":[{"name":"LAM"},{"name":"Lymphangio-myomatosis"}],"identifiers":[{"identifierType":"OMIM","identifierId":"606690"},{"identifierType":"ORPHANET","identifierId":"538"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":21,"diseaseTypeName":"Lung Diseases","source":"Orphanet"}],"organizations":[{"resourceID":254,"resourceName":"American Lung Association","abbreviation":"","address1":"55 W. Wacker Drive, Suite 1150","address2":"","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60601","country":"United States","phone":"","tty":"","tollFree":"1-800-548-8252 (1-800-LUNGUSA)","fax":"","email":"info@lung.org","url":"https://www.lung.org/","freeText":""},{"resourceID":85,"resourceName":"The LAM Foundation","abbreviation":"","address1":"4520 Cooper Road, Suite 300","address2":"","address3":"","address4":"","address5":"","city":"Cincinnati","state":"OH","zip":"45242","country":"United States","phone":"513-777-6889","tty":"","tollFree":"877-CURE-LAM","fax":"513-777-4109","email":"info@thelamfoundation.org","url":"http://www.thelamfoundation.org/","freeText":""},{"resourceID":820,"resourceName":"European LAM Patient Federation","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"info@europelamfederation.org","url":"http://www.europelamfederation.org/"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/606690' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=606690' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Lymphangioleiomyomatosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Lymphangioleiomyomatosis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Lymphangioleiomyomatosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://ghr.nlm.nih.gov/condition/lymphangioleiomyomatosis' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Lymphangioleiomyomatosis. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":42,"resourceId":916,"resourceName":"RDCRN - Rare Lung Diseases Consortium","descriptionText":"<p><a target=\"_blank\" href=\"https://www.rarediseasesnetwork.org/rldc/index.htm\">The&nbsp;Rare Lung Diseases Consortium: Molecular Pathway-Driven Diagnostics and Therapeutics for Rare Lung Diseases</a> is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research involving pulmonary alveolar proteinosis, Hermansky-Pudlak Syndrome, and Lymphangioleiomyomatosis. A pilot project program supports research into other rare lung diseases that complement the main research projects.</p>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/lymphangioleiomyomatosis' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":400,"resourceId":1211,"resourceName":"Tuberous Sclerosis Alliance LAM test","descriptionText":"The <a href='http://www.tsalliance.org/pages.aspx?content=647 ' target='_blank'>Tuberous Sclerosis Alliance</a> provides information about a new diagnostic test for lymphangioleiomyomatosis (LAM). This testÂ measures vascular endothelial growth factor D (VEGF-D), which is known to be elevated in the blood of people with LAM, including those with tuberous sclerosis. ","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0751674' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/410/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/radio/TOPIC415.HTM' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"Orphanet is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n<a href='http://www.orpha.net/data/patho/GB/uk-LAM.pdf' target='_blank'>Orphanet</a><br /><a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=538' target='_blank'>Orphanet</a><br />","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1558,"resourceId":2184,"resourceName":"National Heart, Lung, and Blood Institute","descriptionText":"The <a href='http://www.nhlbi.nih.gov/health/health-topics/topics/lam/' target='_blank'>National Heart, Lung, and Blood Institute</a> (NHLBI) has information on this topic. NHLBI is part of the National Institutes of Health and supports research, training, and education for the prevention and treatment of heart, lung, and blood diseases.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:606690' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2611,"resourceId":254,"resourceName":"American Lung Association","descriptionText":"The&nbsp;<a href='http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/lymphangioleiomyomatosis-lam/' target='_blank'>American Lung Association</a> has information about&nbsp;Lymphangioleiomyomatosis.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2612,"resourceId":85,"resourceName":"The LAM Foundation","descriptionText":"<a href='https://www.thelamfoundation.org/Healthcare-Providers-Diagnosis-Treatment-Treatment-Guidelines' target='_blank'>The LAM Foundation</a> provides links to clinical practice guidelines for the treatment of LAM. These guidelines were developed by the&nbsp;American Thoracic Society&nbsp;and the Japanese Respiratory Society&nbsp;in conjunction with an ad hoc guideline development committee of LAM experts.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2613,"resourceId":85,"resourceName":"The LAM Foundation","descriptionText":"<a href='https://www.thelamfoundation.org/Healthcare-Providers/Diagnosis-Treatment/US-LAM-Clinics' target='_blank'>The LAM Foundation</a> provides a directory of LAM clinics across the United States.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"}],"overviewQuestion":{"questionId":234,"questionText":"What is lymphangioleiomyomatosis (LAM)?","answerText":"<strong>Lymphangioleiomyomatosis</strong> (lim-FAN-je-o-LI-o-MI-o-ma-TO-sis), or LAM, is a rare cystic lung disease that mostly affects women in their mid-forties. In LAM, an unusual type of cell begins to grow out of control throughout the body, including in the lungs, lymph nodes and vessels, and kidneys. Over time, these LAM cells form <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003240.htm\">cysts</a> and clusters of cells, which grow throughout the lungs and slowly block the airways. They also destroy the normal lung tissue and replace it with cysts. As a result, air cannot move freely in and out of the lungs, and the lungs cannot supply enough oxygen to the body&rsquo;s other organs. Some people also develop growths called <a href=\"http://emedicine.medscape.com/article/376848-overview\">angiomyolipomas</a>&nbsp;(AMLs) in the kidneys. There are two forms of LAM - a sporadic form, which occurs for unknown reasons, and a form that<span style=\"font-size: 12pt;\">&nbsp;occurs in people with a rare, inherited disease called </span><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000787.htm\" target=\"_blank\" style=\"font-size: 12pt;\">tuberous sclerosis complex</a><span style=\"font-size: 12pt;\">.[167]<br />\r\n<br />\r\nLAM may be difficult to diagnosis in the early stages because symptoms may be similar to other lung diseases. A high resolution CT scan is the most accurate imaging test for diagnosing LAM. Additional testing may include an abdominal CT scan or ultrasound, a VEGF-D blood test (measuring the VEGF-D hormone, which would typically be high), and a lung biopsy.[178] There are several management options for LAM, but the best course of treatment may vary from person to person. Treatment options may include therapy with an mTOR inhibitor (such as&nbsp;<a href=\"https://medlineplus.gov/druginfo/meds/a602026.html\" target=\"_blank\">sirolimus</a>), and supportive measures such as <a href=\"https://medlineplus.gov/oxygentherapy.html\" target=\"_blank\">oxygen therapy</a>&nbsp;or the use of <a href=\"https://kidshealth.org/en/parents/bronchodilator.html\" target=\"_blank\">bronchodilators</a>. Some people may need a lung transplant when lung function is considerably impaired.[14698]</span>","dateModified":"2018-06-05T00:00:00"},"basicQuestions":[{"questionId":240,"questionText":"How is lymphangioleiomyomatosis (LAM) treated?","answerText":"While there is currently no cure for LAM, research has led to major progress in the treatment of symptoms. Treatment options may vary from person to person depending on the severity of the disease. People with LAM should speak with their doctor about whether certain options are right for them, as well as the benefits and risks of treatment options.<br />\r\n<br />\r\nTreatment for LAM may involve:[14698]<br />\r\n<ul>\r\n    <li><a href=\"https://medlineplus.gov/druginfo/meds/a602026.html\" target=\"_blank\">Sirolimus</a> (also called rapamycin) - this medicine works to stabilize lung function, treat chylothorax (abnormal fluid buildup in the lung), and shrink abnormal kidney and lymph node growths. Sirolimus has been shown to improve quality of life in patients with moderate to severe LAM. </li>\r\n    <li><a href=\"https://medlineplus.gov/oxygentherapy.html\" target=\"_blank\">Oxygen therapy</a> - this may be recommended if the level of oxygen in the blood is low, and may become necessary as lung function worsens.</li>\r\n    <li><a href=\"https://kidshealth.org/en/parents/bronchodilator.html\" target=\"_blank\">Bronchodilators</a> - these medicines relax muscles around the airways and may make it easier to breathe. They may be prescribed for people with LAM who are wheezing or have difficulty breathing.</li>\r\n    <li>Procedures that remove air or fluid from the chest or abdomen - these may help with shortness of breath and relieving discomfort.</li>\r\n    <li>Procedures or surgeries that remove or shrink kidney tumors, which may cause pain or bleeding.</li>\r\n    <li><a href=\"https://www.nhlbi.nih.gov/health-topics/lung-transplant\" target=\"_blank\">Lung transplant</a> - people with LAM who have severe symptoms and/or severe lung damage may be eligible for a lung transplant.</li>\r\n</ul>\r\n<p>Of note, <span style=\"font-size: 12pt;\">doxycycline and hormone-based therapy, which have previously been used in the treatment LAM, are no longer recommended treatments.<br />\r\n<br />\r\n</span><span style=\"font-size: 12pt;\">The American Thoracic Society and Japanese Respiratory Society have made available their&nbsp;</span><span style=\"font-size: 12pt;\">latest <a href=\"https://www.thelamfoundation.org/Healthcare-Providers-Diagnosis-Treatment-Treatment-Guidelines\" target=\"_blank\">clinical practice guidelines for LAM</a> which include the current treatment recommendations.</span></p>","dateModified":"2018-06-05T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":167,"authors":"","articleTitle":"LAM","bookWebsiteJournalTitle":"National Heart Lung and Blood Institute (NHLBI)","date":"","volume":"","pages":"","url":"http://www.nhlbi.nih.gov/health/health-topics/topics/lam/","dateAccessed":"2018-06-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14698,"authors":"","articleTitle":"LAM Management","bookWebsiteJournalTitle":"The LAM Foundation","date":"","volume":"","pages":"","url":"https://www.thelamfoundation.org/Healthcare-Providers/Diagnosis-Treatment/LAM-Management","dateAccessed":"2018-06-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":42398,"abbreviatedInquiry":"Recently, I had an abdominal ultrasound performed and the doctors found what they believe is a small angiomyolipoma. My doctor told me not to worry about it and just to have a follow up in 6 months to make sure it didn't grow in size. While online trying to figure out what an angiomyolipoma was, I came upon LAM, a disease that I previously knew nothing about. What most concerned me was that sporadic LAM is most common in young women (I'm in my 20's) and many of them also have renal angiomyolipoma. While the median age for someone to get an angiomylipoma is mid-50s. I don't believe I have any symptoms of LAM, but still worry about this risk. I guess what I am looking for is some more definitive information?","caseQuestions":[{"questionId":7145,"questionText":"What are the chances that a young woman has LAM if she has a angiomyolipoma?","answerText":"Having a single angiomyolipoma alone would not prompt a&nbsp;high concern for LAM, although consideration for LAM as well as for tuberous sclerosis complex (TSC)&nbsp;is warranted, given that a small percentage of people with a renal (kidney) angiomyolipoma have LAM or TSC. Concern is higher if there are multiple renal angiomyolipomas or cysts.&nbsp;While the frequency of angiomyolipomas in healthy individuals does&nbsp;increase with advancing age, there is limited data regarding age at diagnosis and specific risks. Still, recent studies have estimated that 0.3% to 2.2%&nbsp;of healthy individuals have&nbsp;an angiomyolipoma. These angiomyolipomas are often small, slow growing,&nbsp;and cause no symptoms.[7030]","dateModified":"2013-11-22T14:10:00","references":[{"referenceId":7030,"authors":"Bennett WM, Torres VE","articleTitle":"Renal angiomyolipomas","bookWebsiteJournalTitle":"UpToDate","date":"2013","volume":"","pages":"","url":"http://www.uptodate.com/contents/renal-angiomyolipomas","dateAccessed":"2013-11-22T00:00:00","authors2":"Basow M","placeOfPublication":"Waltham MA","publisher":"UpToDate"}]}]},{"caseId":21099,"abbreviatedInquiry":"Please send me any information regarding treatment and/or clinical trials for this rare disease. ","caseQuestions":[{"questionId":234,"questionText":"What is lymphangioleiomyomatosis (LAM)?","answerText":"<strong>Lymphangioleiomyomatosis</strong> (lim-FAN-je-o-LI-o-MI-o-ma-TO-sis), or LAM, is a rare cystic lung disease that mostly affects women in their mid-forties. In LAM, an unusual type of cell begins to grow out of control throughout the body, including in the lungs, lymph nodes and vessels, and kidneys. Over time, these LAM cells form <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003240.htm\">cysts</a> and clusters of cells, which grow throughout the lungs and slowly block the airways. They also destroy the normal lung tissue and replace it with cysts. As a result, air cannot move freely in and out of the lungs, and the lungs cannot supply enough oxygen to the body&rsquo;s other organs. Some people also develop growths called <a href=\"http://emedicine.medscape.com/article/376848-overview\">angiomyolipomas</a>&nbsp;(AMLs) in the kidneys. There are two forms of LAM - a sporadic form, which occurs for unknown reasons, and a form that<span style=\"font-size: 12pt;\">&nbsp;occurs in people with a rare, inherited disease called </span><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000787.htm\" target=\"_blank\" style=\"font-size: 12pt;\">tuberous sclerosis complex</a><span style=\"font-size: 12pt;\">.[167]<br />\r\n<br />\r\nLAM may be difficult to diagnosis in the early stages because symptoms may be similar to other lung diseases. A high resolution CT scan is the most accurate imaging test for diagnosing LAM. Additional testing may include an abdominal CT scan or ultrasound, a VEGF-D blood test (measuring the VEGF-D hormone, which would typically be high), and a lung biopsy.[178] There are several management options for LAM, but the best course of treatment may vary from person to person. Treatment options may include therapy with an mTOR inhibitor (such as&nbsp;<a href=\"https://medlineplus.gov/druginfo/meds/a602026.html\" target=\"_blank\">sirolimus</a>), and supportive measures such as <a href=\"https://medlineplus.gov/oxygentherapy.html\" target=\"_blank\">oxygen therapy</a>&nbsp;or the use of <a href=\"https://kidshealth.org/en/parents/bronchodilator.html\" target=\"_blank\">bronchodilators</a>. Some people may need a lung transplant when lung function is considerably impaired.[14698]</span>","dateModified":"2018-06-05T00:00:00","references":[{"referenceId":167,"authors":"","articleTitle":"LAM","bookWebsiteJournalTitle":"National Heart Lung and Blood Institute (NHLBI)","date":"","volume":"","pages":"","url":"http://www.nhlbi.nih.gov/health/health-topics/topics/lam/","dateAccessed":"2018-06-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":178,"authors":"","articleTitle":"Diagnosing LAM","bookWebsiteJournalTitle":"The LAM Foundation","date":"","volume":"","pages":"","url":"https://www.thelamfoundation.org/Healthcare-Providers/Diagnosis-Treatment/Diagnosing-LAM","dateAccessed":"2018-06-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14698,"authors":"","articleTitle":"LAM Management","bookWebsiteJournalTitle":"The LAM Foundation","date":"","volume":"","pages":"","url":"https://www.thelamfoundation.org/Healthcare-Providers/Diagnosis-Treatment/LAM-Management","dateAccessed":"2018-06-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":240,"questionText":"How is lymphangioleiomyomatosis (LAM) treated?","answerText":"While there is currently no cure for LAM, research has led to major progress in the treatment of symptoms. Treatment options may vary from person to person depending on the severity of the disease. People with LAM should speak with their doctor about whether certain options are right for them, as well as the benefits and risks of treatment options.<br />\r\n<br />\r\nTreatment for LAM may involve:[14698]<br />\r\n<ul>\r\n    <li><a href=\"https://medlineplus.gov/druginfo/meds/a602026.html\" target=\"_blank\">Sirolimus</a> (also called rapamycin) - this medicine works to stabilize lung function, treat chylothorax (abnormal fluid buildup in the lung), and shrink abnormal kidney and lymph node growths. Sirolimus has been shown to improve quality of life in patients with moderate to severe LAM. </li>\r\n    <li><a href=\"https://medlineplus.gov/oxygentherapy.html\" target=\"_blank\">Oxygen therapy</a> - this may be recommended if the level of oxygen in the blood is low, and may become necessary as lung function worsens.</li>\r\n    <li><a href=\"https://kidshealth.org/en/parents/bronchodilator.html\" target=\"_blank\">Bronchodilators</a> - these medicines relax muscles around the airways and may make it easier to breathe. They may be prescribed for people with LAM who are wheezing or have difficulty breathing.</li>\r\n    <li>Procedures that remove air or fluid from the chest or abdomen - these may help with shortness of breath and relieving discomfort.</li>\r\n    <li>Procedures or surgeries that remove or shrink kidney tumors, which may cause pain or bleeding.</li>\r\n    <li><a href=\"https://www.nhlbi.nih.gov/health-topics/lung-transplant\" target=\"_blank\">Lung transplant</a> - people with LAM who have severe symptoms and/or severe lung damage may be eligible for a lung transplant.</li>\r\n</ul>\r\n<p>Of note, <span style=\"font-size: 12pt;\">doxycycline and hormone-based therapy, which have previously been used in the treatment LAM, are no longer recommended treatments.<br />\r\n<br />\r\n</span><span style=\"font-size: 12pt;\">The American Thoracic Society and Japanese Respiratory Society have made available their&nbsp;</span><span style=\"font-size: 12pt;\">latest <a href=\"https://www.thelamfoundation.org/Healthcare-Providers-Diagnosis-Treatment-Treatment-Guidelines\" target=\"_blank\">clinical practice guidelines for LAM</a> which include the current treatment recommendations.</span></p>","dateModified":"2018-06-05T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":167,"authors":"","articleTitle":"LAM","bookWebsiteJournalTitle":"National Heart Lung and Blood Institute (NHLBI)","date":"","volume":"","pages":"","url":"http://www.nhlbi.nih.gov/health/health-topics/topics/lam/","dateAccessed":"2018-06-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14698,"authors":"","articleTitle":"LAM Management","bookWebsiteJournalTitle":"The LAM Foundation","date":"","volume":"","pages":"","url":"https://www.thelamfoundation.org/Healthcare-Providers/Diagnosis-Treatment/LAM-Management","dateAccessed":"2018-06-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":253,"questionText":"Are there currently any clinical trials for lymphangioleiomyomatosis (LAM)?","answerText":"The U.S. National Institutes of Health, through the National Library of Medicine, developed <a href=\"http://www.clinicaltrials.gov\" target=_blank>ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies To learn more about how you can become involved in clinical research, please see the <a href=\"http://rarediseases.info.nih.gov/gard/3319/lymphangioleiomyomatosis/resources/6\">Research</a> section of this webpage. <br><br><a href=\"http://www.thelamfoundation.org/research/current-lam-research\">The LAM Foundation</a> supports past an ongoing research for the causes and treatment of LAM. The LAM Foundation continues to support clinical trials to search for safe and effective treatments.[178]<br><br>The National Institutes of Health (NIH) established the Rare Diseases Clinical Research Network (RDCRN) to facilitate collaboration among experts in many different types of rare diseases. The goal of the network is to contribute to the research and treatment of rare diseases by working together to identify biomarkers for disease risk, disease severity and activity, and clinical outcome, while also encouraging development of new approaches to diagnosis, prevention, and treatment. The RDCRN consists of ten consortia and a Data and Technology Coordinating Center (DTCC). One of these consortia is the Rare Lung Diseases Consortium (RLDC), a network of cooperating clinical centers and patient support organizations that are working with the National Institutes of Health (NIH) in a collaborative network whose novel structure is designed to accelerate clinical research and improve the delivery of medical care to individuals affected by rare lung diseases. To join the Contact Registry for LAM, <a href=\"https://rarediseasesnetwork.epi.usf.edu/rdnwebapp/registry/descriptionandpurpose.aspx?ownerid=7&amp;diseasetype=36\">click here</a>.","dateModified":"2013-07-16T15:16:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":11831,"phenoTypeName":"Chest pain","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9070,"phenoTypeName":"Cough","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13726,"phenoTypeName":"Dyspnea","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13741,"phenoTypeName":"Pulmonary infiltrates","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13724,"phenoTypeName":"Restrictive ventilatory defect","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6540,"phenoTypeName":"Abnormal morphology of female internal genitalia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11832,"phenoTypeName":"Atelectasis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13173,"phenoTypeName":"Chylothorax","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13727,"phenoTypeName":"Emphysema","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14161,"phenoTypeName":"Hematuria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13313,"phenoTypeName":"Lymphadenopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13738,"phenoTypeName":"Pneumothorax","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8791,"phenoTypeName":"Pulmonary lymphangiomyomatosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12116,"phenoTypeName":"Renal angiomyolipoma","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1871,"phenoTypeName":"Ungual fibroma","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2688,"phenoTypeName":"Abnormal urinary color","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8280,"phenoTypeName":"Abnormality of skin pigmentation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4096,"phenoTypeName":"Ascites","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13906,"phenoTypeName":"Chylopericardium","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13704,"phenoTypeName":"Fatigue","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8110,"phenoTypeName":"Gastrointestinal hemorrhage","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13737,"phenoTypeName":"Hemoptysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9825,"phenoTypeName":"Hydrocephalus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8283,"phenoTypeName":"Lymphedema","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9068,"phenoTypeName":"Macule","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9599,"phenoTypeName":"Multiple renal cysts","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8075,"phenoTypeName":"Recurrent respiratory infections","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5840,"phenoTypeName":"Retinal hamartoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15148,"phenoTypeName":"Shagreen patch","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8123,"phenoTypeName":"Somatic mutation","percentRanges":"-"}],"medicalProducts":[{"productId":638,"genericName":"Sirolimus","tradeName":"Rapamune","tradeLink":"http://www.pfizer.com/news/press-release/press-release-detail/pfizer_s_rapamune_sirolimus_becomes_first_fda_approved_treatment_for_lymphangioleiomyomatosis_lam_a_rare_progressive_lung_disease","manufacturer":"","sponsor":"Pfizer, Inc.","indication":"Treatment of lymphangioleiomyomatosis","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=RAPAMUNE","medlinePlusLink":"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a602026.html"}],"EncodedName":"Lymphangioleiomyomatosis"}